When to Administer Isosorbide Dinitrate (Sorbitrate) for Angina
Isosorbide dinitrate should be administered for acute angina symptoms that are unrelieved after 3 doses of sublingual nitroglycerin taken 5 minutes apart, for prophylaxis before activities known to trigger angina, and as maintenance therapy for chronic stable angina using a non-tolerance producing regimen (twice daily with a nitrate-free interval). 1, 2
Acute Angina Management
- For patients experiencing acute angina symptoms, sublingual isosorbide dinitrate (5-10 mg) can be administered if symptoms persist after taking sublingual nitroglycerin 3
- If a patient has previously been prescribed nitroglycerin, they should first take 1 nitroglycerin dose sublingually for chest discomfort/pain 1
- If symptoms are unimproved or worsening 5 minutes after the first nitroglycerin dose, the patient should call emergency services (9-1-1) 1
- While awaiting emergency services, patients may take additional nitroglycerin every 5 minutes for a maximum of 3 doses if they tolerate it well 1
- For patients with chronic stable angina who experience significant improvement after one nitroglycerin dose, it is appropriate to repeat nitroglycerin every 5 minutes for a maximum of 3 doses and call emergency services if symptoms have not completely resolved 1
Intravenous Administration
- For patients with refractory or severe unstable angina in hospital settings, intravenous isosorbide dinitrate may be initiated at 10 mcg/min and increased by 10 mcg/min every 3-5 minutes until symptom relief or blood pressure response 1, 4
- If no response is seen at 20 mcg/min, increments of 10 and later 20 mcg/min can be used 1
- A ceiling dose of 200 mcg/min is commonly used, though higher doses have been safely administered 4
- Systolic blood pressure should not be titrated below 110 mmHg in previously normotensive patients or more than 25% below baseline in hypertensive patients 1
- Intravenous nitrates should be avoided in patients with initial systolic blood pressure less than 90 mmHg, or 30 mmHg below baseline, or with marked bradycardia or tachycardia 1
Maintenance Therapy for Chronic Angina
- For chronic stable angina, oral isosorbide dinitrate can be administered at 5-80 mg, 2-3 times daily, with effects lasting up to 8 hours 1
- Anti-anginal activity begins approximately 1 hour after oral dosing 2
- To avoid nitrate tolerance, use a regimen with one daily dose-free interval of at least 14 hours (e.g., dosing at 8 AM and 2 PM) 2, 5
- The maximal achievable daily duration of anti-anginal effect from isosorbide dinitrate is about 12 hours 2
- During sustained therapy, partial tolerance develops rapidly, with antianginal effects lasting only about 2 hours compared to 8 hours during acute therapy 6
Dosing Considerations
- For oral therapy, starting doses of 5-10 mg are typically effective, with hemodynamic effects usually apparent at 15 minutes, peaking between 30-120 minutes, and lasting up to 4 hours 7
- For most patients, near maximal improvement in exercise tolerance occurs with doses of 15-30 mg four times daily 6
- Higher doses (60-120 mg) do not necessarily provide additional benefit during sustained therapy 6
- Slow-release formulations can be administered at 40 mg once or twice daily with effects lasting up to 8 hours 1
Contraindications and Precautions
- Isosorbide dinitrate is contraindicated within 24 hours of sildenafil use or 48 hours of tadalafil use due to risk of profound hypotension, MI, and even death 1, 4
- Avoid in patients with severe hypotension (systolic BP <90 mmHg) 1
- Common side effects include headache and hypotension 1
- Tolerance to hemodynamic effects typically develops after 24 hours of continuous therapy 1
Special Considerations
- For vasospastic (variant) angina, calcium channel blockers together with nitrates are the mainstay of treatment 3
- When switching from intravenous to oral/topical nitrates, use a non-tolerance producing regimen (lower doses and intermittent dosing) 1
- For patients requiring nitrate therapy beyond 24 hours, periodic increases in dosage may be needed to maintain efficacy 4